EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology

被引：11
|
作者：
Graziano, Paolo [1 ]
de Marinis, Filippo [1 ]
Gori, Bruno [1 ]
Gasbarra, Rita [1 ]
Migliorino, Rita [1 ]
De Santis, Stefano [1 ]
Pelosi, Giuseppe [2 ,3 ]
Leone, Alvaro [1 ]
机构：
[1] San Camillo Forlanini Hosp, Rome, Italy
[2] Fdn Ist Ricovero & Cura Carattere Sci, Ist Tumori, Milan, Italy
[3] Univ Milan, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
LUNG-CANCER; GEFITINIB; ERLOTINIB; PATIENT;
D O I：
10.1200/JCO.2013.49.5697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E115 / E118
页数：4
相关论文
共 50 条
  • [41] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
    Akamatsu, Hiroaki
    Katakami, Nobuyuki
    Okamoto, Isamu
    Kato, Terufumi
    Kim, Young Hak
    Imamura, Fumio
    Shinkai, Masaharu
    Hodge, Rachel A.
    Uchida, Hirohiko
    Hida, Toyoaki
    CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
  • [42] Liquid biopsy to diagnose EGFR T790M mutation in previously radiated non-small-cell lung cancer brain metastases and rapid response to osimertinib
    Matzdorff, A.
    Meier, A.
    Lenze, D.
    Hartmann, J.
    Pielsticker, C.
    Gawliczek, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 231 - 231
  • [43] EGFR T790M Mutation A Double Role in Lung Cancer Cell Survival?
    Suda, Kenichi
    Onozato, Ryoichi
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 1 - 4
  • [44] Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
    Vaclova, Tereza
    Grazini, Ursula
    Ward, Lewis
    O'Neill, Daniel
    Markovets, Aleksandra
    Huang, Xiangning
    Chmielecki, Juliann
    Hartmaier, Ryan
    Thress, Kenneth S.
    Smith, Paul D.
    Barrett, J. Carl
    Downward, Julian
    de Bruin, Elza C.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [45] Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance
    Wang, Ying
    Liu, Qiuyun
    Chen, Haojie
    You, Jun
    Peng, Bin
    Cao, Fanfan
    Zhang, Xue
    Chen, Qing
    Uzan, Georges
    Xu, Limin
    Zhang, Denghai
    ANTI-CANCER DRUGS, 2018, 29 (08) : 748 - 755
  • [46] High sensitivity detection of epidermal growth factor receptor (EGFR) T790M mutants in non-small-cell lung cancer
    Tracey, J.
    Clark, C.
    Bell, C.
    Kerr, K. M.
    Nicolson, M.
    Miedzybrodzka, Z.
    Kelly, K.
    LUNG CANCER, 2013, 79 : S7 - S8
  • [47] Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
    Tereza Vaclova
    Ursula Grazini
    Lewis Ward
    Daniel O’Neill
    Aleksandra Markovets
    Xiangning Huang
    Juliann Chmielecki
    Ryan Hartmaier
    Kenneth S. Thress
    Paul D. Smith
    J. Carl Barrett
    Julian Downward
    Elza C. de Bruin
    Nature Communications, 12
  • [48] The Usefulness of "Serum" Samples to Detect EGFR T790M Mutation in EGFR-TKI-Resistant Non-Small Cell Lung Cancer
    Kobayashi, K.
    Naoki, K.
    Ikemura, S.
    Yasuda, H.
    Kawada, I.
    Soejima, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S936 - S937
  • [49] Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
    Lee, J. C.
    Yang, S.
    Oh, D. K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S806 - S807
  • [50] Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
    Li, Hang
    Hu, Haichuan
    Wang, Rui
    Pan, Yunjian
    Wang, Lei
    Li, Yuan
    Zhang, Yang
    Ye, Ting
    Zhang, Yiliang
    Li, Bin
    Shen, Lei
    Sun, Yihua
    Chen, Haiquan
    ONCOTARGETS AND THERAPY, 2014, 7 : 513 - 524
12345